HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors
HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors
Recruiting · NCT05861895 · Registry updated 2026-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors | Solid Tumors, Adult | Recruiting | Phase 1 | 2026-06-26 | NCT05861895 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| HighField Biopharmaceuticals Corporation | 4 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mary Crowley Cancer Research | Dallas | United States | 1 |
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |